Ozempic and Wegovy both contain semaglutide but differ in dosage and primary use; Wegovy is specifically approved for weight loss at higher doses, while Ozempic is mainly for diabetes and weight management.
Ozempic and Wegovy are injectable medications containing semaglutide, a GLP-1 receptor agonist that helps regulate appetite and blood sugar. Both drugs are manufactured by Novo Nordisk and share similar mechanisms but serve different primary indications.
Ozempic is approved for managing type 2 diabetes and can aid weight loss as a secondary benefit. Wegovy is specifically approved for chronic weight management in adults with obesity or overweight with related health conditions.
Ozempic is typically prescribed at lower weekly doses (0.5 mg to 1 mg) for diabetes, with weight loss as a secondary effect. Wegovy uses higher doses (2.4 mg weekly) designed explicitly for weight loss, requiring careful titration under medical supervision.
Clinical trials show Wegovy leads to an average weight loss of around 15-20% of body weight over 68 weeks. Ozempic also promotes weight reduction but generally results in slightly less weight loss compared to Wegovy at similar durations.
Both medications may cause nausea, diarrhea, and vomiting. There is a rare risk of thyroid tumors; therefore, medical guidance is essential. Wegovy's higher dose may increase the likelihood of gastrointestinal side effects.
Both drugs should be used under healthcare supervision, especially for individuals with a history of thyroid tumors or pancreatitis. Regular monitoring of weight, blood sugar, and side effects is recommended.
The decision depends on your specific health goals, medical history, and doctor's recommendation. Klarity offers online consultation services to evaluate your suitability for either medication and provide prescriptions after assessment.
Klarity connects you with licensed healthcare providers who can review your health profile and prescribe Ozempic or Wegovy online. Our services include virtual consultations, personalized treatment plans, and medication management, ensuring safe use.
These medications are prescription-only. Always consult a healthcare professional for personalized advice. Do not start or stop any medication without medical guidance. Klarity’s services are for educational purposes and do not replace medical diagnosis or treatment.
Ozempic and Wegovy are injectable medications with semaglutide, used for diabetes and weight management, with Wegovy specifically approved for weight loss.
Ozempic is for diabetes with weight loss as a secondary benefit; Wegovy is higher-dose semaglutide approved explicitly for weight loss.
Both have side effects like nausea and potential thyroid risks; medical supervision is essential to ensure safety.
No, these are prescription medications that require evaluation and guidance from a healthcare provider.
Klarity connects you with licensed healthcare providers who can evaluate your needs and prescribe Ozempic or Wegovy online after a consultation.